扩大G蛋白合受体Rhodopsin的功能分析
Benjamin M Scott1, Steven K Chen1, Alexander Van Nynatten1
1Department of Cell and Systems Biology, University of Toronto, Toronto, ON, Canada.
Journal of molecular evolution
|February 7, 2024
概括
我们开发了一种高通量试验,用于测量G蛋白结合受体 (GPCR) 罗多普辛的突变. 这种深度突变扫描方法揭示了突变如何影响罗多素激活和蛋白质结构,有助于了解疾病变异.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- G蛋白结合受体 (GPCRs) 调解细胞对外部刺激的反应.
- 了解GPCR基因突变如何影响受体激活和信号传递至关重要.
- 现有的研究GPCR突变的方法,如深度突变扫描,缺乏对罗多激活的高吞吐量测量.
研究的目的:
- 在芽酵母中开发和扩展高通量光记者试验,以测量罗多素激活.
- 为了研究1200多个人类罗多素突变体的功能影响.
- 根据其3D结构分析罗多普辛的突变耐受性,并将发现与疾病变异相关联.
主要方法:
- 在芽酵母中设计了一个光记者分析,以研究罗多素的光激活信号传导.
- 通过RHO基因的低频随机突变生成超过1200个人类罗多素突变.
- 进行了深度突变扫描,以测量每个突变的功能影响.
主要成果:
- 确定了1200多种罗多普辛突变体,并测量了它们对激活的功能影响.
- 确定跨膜螺旋的突变耐受性低于面向脂质双层的螺旋,表明结构依赖的突变耐受性.
- 发现许多致病性罗多普辛突变体表现出功能丧失,与临床观察和复杂的对抗机制一致.
结论:
- 深度突变扫描是一种可行的和有效的方法来研究罗多激活.
- 该研究提供了关于罗多素结构内的突变耐受性的见解,可能适用于其他跨膜蛋白.
- 这些发现有助于理解与罗多普辛相关的疾病以及受体激活的机制.
相关概念视频
Activation and Inactivation of G Proteins
7.2K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
7.2K
Channel Rhodopsins
2.6K
Most organisms use photoreceptors to sense and respond to light. Examples of photoreceptors include bacteriorhodopsins and bacteriophytochromes in some bacteria, phytochromes in plants, and rhodopsins in the photoreceptor cells of the vertebral retina. The light-sensitive property of these receptors is because of the bound chromophores, such as bilin in the phytochromes and retinal in the rhodopsins.
Rhodopsins belong to the family of cell surface proteins called G-protein coupled receptors,...
Rhodopsins belong to the family of cell surface proteins called G-protein coupled receptors,...
2.6K
G-Protein Gated Ion Channels
4.6K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.6K
G Protein-coupled Receptors
12.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
12.1K
G-protein Coupled Receptors
118.9K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
118.9K
Transducer Mechanism: G Protein–Coupled Receptors
2.0K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
2.0K


